Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QML9 | ISIN: KYG6082P1054 | Ticker-Symbol: 72X
Frankfurt
06.06.25 | 08:04
0,084 Euro
-2,91 % -0,003
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
MICROPORT CARDIOFLOW MEDTECH CORPORATION Chart 1 Jahr
5-Tage-Chart
MICROPORT CARDIOFLOW MEDTECH CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
0,0800,11306.06.
0,0850,10906.06.

Aktuelle News zur MICROPORT CARDIOFLOW MEDTECH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiCARDIOFLOW-B (02160): FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, JUNE 27, 20252
MiCARDIOFLOW-B (02160): NOTICE OF ANNUAL GENERAL MEETING1
MiCARDIOFLOW-B (02160): (1) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES; (2) PROPOSED RE-ELECTION OF THE RETIRING ...-
30.05.CARDIOFLOW-B (02160): DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF THE REMAINING 49.00% EQUITY INTEREST IN MP CARDIOADVENT-
MICROPORT CARDIOFLOW MEDTECH Aktie jetzt für 0€ handeln
29.04.CARDIOFLOW-B (02160): 2024 ANNUAL REPORT-
01.04.CARDIOFLOW-B (02160): CONTINUING CONNECTED TRANSACTION IN RELATION TO THE PROPERTY LEASE AGREEMENT1
28.03.CARDIOFLOW-B (02160): GRANT OF SHARE OPTIONS-
27.03.CARDIOFLOW-B (02160): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024-
27.03.CARDIOFLOW-B (02160): TERMS OF REFERENCE OF THE NOMINATION COMMITTEE1
27.03.CARDIOFLOW-B (02160): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS5
27.03.CARDIOFLOW-B (02160): CHANGE OF EXECUTIVE DIRECTOR AND PRESIDENT-
17.03.CARDIOFLOW-B (02160): DATE OF BOARD MEETING1
06.03.CARDIOFLOW-B (02160): PROFIT FORECAST FOR THE YEAR OF 2024 - SIGNIFICANT REDUCTION IN NET LOSS-
21.02.CARDIOFLOW-B (02160): CE MARK APPROVAL OF ANCHORMAN LAAC SYSTEM AND ITS ACCESS SYSTEM2
17.12.24CARDIOFLOW-B (02160): VOLUNTARY ANNOUNCEMENT - NMPA APPROVAL FOR REGISTRATION OF VITAFLOW LIBERTY FLEX1
17.06.24MicroPort CardioFlow Medtech Corporation: CardioFlow's VitaFlow Liberty Granted EU CE-MDR Mark, Advancing Global Expansion Roadmap935SHANGHAI, June 17, 2024 /PRNewswire/ -- MicroPort® CardioFlow Medtech Corporation (CardioFlow) (Stock Code: 02160.HK) recently announced that its self-developed second-generation transcatheter...
► Artikel lesen
16 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1